SK80195A3 - Method of preparation for effective toxoplasma gondii bradyzoit vaccine in the tissue culture - Google Patents

Method of preparation for effective toxoplasma gondii bradyzoit vaccine in the tissue culture Download PDF

Info

Publication number
SK80195A3
SK80195A3 SK801-95A SK80195A SK80195A3 SK 80195 A3 SK80195 A3 SK 80195A3 SK 80195 A SK80195 A SK 80195A SK 80195 A3 SK80195 A3 SK 80195A3
Authority
SK
Slovakia
Prior art keywords
tissue culture
gondii
vaccine
bradyzoites
tachyzoites
Prior art date
Application number
SK801-95A
Other languages
English (en)
Slovak (sk)
Inventor
Irene Popiel
Marielle Gold
Leszek J Choromanski
Karen K Brown
Original Assignee
Bayer Ag
Paravax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Paravax Inc filed Critical Bayer Ag
Publication of SK80195A3 publication Critical patent/SK80195A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SK801-95A 1994-06-17 1995-06-15 Method of preparation for effective toxoplasma gondii bradyzoit vaccine in the tissue culture SK80195A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26155594A 1994-06-17 1994-06-17

Publications (1)

Publication Number Publication Date
SK80195A3 true SK80195A3 (en) 1996-05-08

Family

ID=22993846

Family Applications (1)

Application Number Title Priority Date Filing Date
SK801-95A SK80195A3 (en) 1994-06-17 1995-06-15 Method of preparation for effective toxoplasma gondii bradyzoit vaccine in the tissue culture

Country Status (7)

Country Link
EP (1) EP0687471A1 (fr)
JP (1) JPH08188515A (fr)
AU (1) AU2041995A (fr)
CA (1) CA2149197A1 (fr)
CZ (1) CZ156195A3 (fr)
PL (1) PL309104A1 (fr)
SK (1) SK80195A3 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514694B2 (en) 1997-12-19 2003-02-04 Heska Corporation Methods for the detection of encysted parasites
CA2377131A1 (fr) * 1999-05-04 2000-11-09 Rima W. Mcleod Agents anti-microbiens, reactifs diagnostiques et vaccins a base de constituants specifiques du parasite apicomplexan
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
JP2014527799A (ja) 2011-08-26 2014-10-23 ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション 変異型ｐｂ２遺伝子セグメントを有する弱毒化生ワクチンとしてのインフルエンザウイルス
US10053671B2 (en) 2014-06-20 2018-08-21 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
US11197925B2 (en) 2016-02-19 2021-12-14 Wisconsin Alumni Research Foundation (Warf) Influenza B virus replication for vaccine development
WO2019084310A1 (fr) 2017-10-25 2019-05-02 Yoshihiro Kawaoka Virus de la grippe recombinants à ha stabilisé pour la réplication dans des oeufs
WO2019241579A1 (fr) * 2018-06-13 2019-12-19 Wisconsin Alumni Research Foundation Toxoplasma gondii utilisé comme vaccin
JP7655849B2 (ja) 2018-08-20 2025-04-02 ウィスコンシン アルムニ リサーチ ファンデイション ヘマグルチニン（ｈａ）タンパク質内の非ドミナントエピトープに対する免疫応答を誘起するためのベクター
EP3921413A1 (fr) 2019-02-08 2021-12-15 Wisconsin Alumni Research Foundation (WARF) Lignée cellulaire humanisée
CN114929269A (zh) 2019-05-01 2022-08-19 威斯康星校友研究基金会(Warf) 用于疫苗开发的改进的流感病毒复制
US11807872B2 (en) 2019-08-27 2023-11-07 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized HA for replication in eggs
JP2023511444A (ja) 2020-01-24 2023-03-17 ウィスコンシン アルムニ リサーチ ファンデイション 安定化されたｎａを有する組換えインフルエンザウイルス
WO2021195410A1 (fr) 2020-03-25 2021-09-30 Wisconsin Alumni Research Foundation (Warf) Virus de la grippe multivalents recombinants
WO2024250024A2 (fr) * 2023-06-02 2024-12-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Vaccin pour chats pour bloquer la libération et la transmission de toxoplasma oocyst
EP4574167A1 (fr) 2023-12-19 2025-06-25 Saluvet-Innova S.L. Vaccin inactivé à base de tachyzoite et de protéines natives de bradyzoite de toxoplasma gondii

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473549A (en) * 1982-07-30 1984-09-25 The Kansas University Endowment Association Method for the immunization of animals and men against Toxoplasma gondii _
US5045313A (en) * 1989-07-07 1991-09-03 The University Of Kansas Vaccine for immunizing cats against toxoplasma oocyst shedding

Also Published As

Publication number Publication date
CZ156195A3 (en) 1996-01-17
JPH08188515A (ja) 1996-07-23
PL309104A1 (en) 1995-12-27
EP0687471A1 (fr) 1995-12-20
AU2041995A (en) 1996-01-04
CA2149197A1 (fr) 1995-12-18

Similar Documents

Publication Publication Date Title
Fukunaga et al. Getah virus as an equine pathogen
SK80195A3 (en) Method of preparation for effective toxoplasma gondii bradyzoit vaccine in the tissue culture
Pindak et al. Growth and cytopathogenicity of Trichomonas vaginalis in tissue cultures
KR970000233B1 (ko) 개과 코로나비루스 백신
McAllister et al. Infectious pancreatic necrosis virus: protocol for a standard challenge to brook trout
US3520972A (en) Feline virus vaccines obtained by propagation and serial passage attenuation of virulent feline viruses in diploid feline embryo tissue cell serial passage subculture strains
PT98202B (pt) Processo para a preparacao de uma vacina contra a doenca de lyme, compreendendo uma quantidade dos principais antigenios contra b.burgdorferi
EP1578959B1 (fr) Immunisation de poissons contre une infection virale
JPS6216933B2 (fr)
US4320115A (en) Rabies virus vaccine
JPH08187076A (ja) 商業的規模の採取前に濃縮された組織培養物が生産する生のＴ．ゴンデイイ（Ｔ．ｇｏｎｄｉｉ）のブラデイゾイト、ならびに製品および方法
DE69836976T2 (de) Neospora impstoff
Hotchin The contamination of laboratory animals with lymphocytic choriomeningitis virus
Smorodintsev Basic mechanisms of nonspecific resistance to viruses in animals and man
JP2001516205A (ja) 単離された寄生体腸管生細胞
JPH04507098A (ja) トキソプラズマオーシストの散布に対してネコを免疫感作するためのワクチン
Awad et al. Preliminary studies of a newly developed subunit vaccine for channel catfish virus disease
El-Bahnasawy et al. The Rift Valley fever: could re-emerge in Egypt again?
JP2892767B2 (ja) イヌコロナウイルスワクチン
KR20000070736A (ko) 전염성 활액낭염 백신
Thorne et al. Plague in a free-ranging mule deer from Wyoming
DE3136430A1 (de) Orfvirus, verfahren zur herstellung eines orfvirus-lebendimpfstoffes und seine verwendung zur parenteralen schutzimpfung gegen die orf-infektionen der schafe und ziegen
BLAškovič Tick-borne Encephalitis in Europe
Motha et al. A comparison of the efficacy of two commercial Aujeszky's disease vaccines with glycoprotein-I deletion in pigs
FI61626B (fi) Foerfarande foer framstaellning av nya rabiesvirusvaccin